Pfizer vaccine efficacy
Arbutus files patent infringement lawsuit against Pfizer/BioNTech over COVID shots
The lawsuit by Arbutus and Genevant says Pfizer/BioNTech engaged in licensing discussions for the technology but they did not "result in a settlement."
mRNA could make flu vaccines more effective - here's how
US CDC still looking at potential stroke risk from Pfizer bivalent COVID shot
COVID increases risk of maternal death - study
US FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke
Health concerns rise as pattern shows people 65 and older were more likely to have an ischemic stroke 21 days after receiving the Pfizer/BioNTech bivalent shot
Parents refuse use of 'vaccine-tainted' donor blood for infant's critical operation
Parents to a baby in need of open-heart surgery in New Zealand have so far refused 'vaccine-tainted' donor blood, citing concerns over the Covid-19 vaccine's side effects.
Pfizer profit beats estimates on higher demand for COVID products
Revenue from the antiviral pill, Paxlovid, exceeded market estimates by more than $1b, while vaccine sales surged 20%, helping the drugmaker reaffirm the combined 2022 revenue forecast of $54b.
Pfizer's Paxlovid reduces COVID risk in seniors regardless of vaccine status -study
Use of Pfizer's pills, authorized to treat newly infected, at-risk people in order to prevent severe illness, has soared in the United States.
Pfizer COVID-19 vaccine prevented almost 700,000 hospitalizations -study
The study also found that the vaccine saved over $30 billion in US healthcare costs and over $40 billion in lost productivity.
COVID-19 vaccine doesn't affect IVF success rates - Israeli study
Sheba Medical Center researchers ultimately found no difference in the rate of pregnancy between the vaccinated and unvaccinated test groups.
Prior COVID offers less protection vs Omicron; mRNA booster shot efficacy declines within months
The immune response to COVID-19 helps protect against reinfection, but that protection is weaker against Omicron than it was against earlier variants of the coronavirus, according to new data.
Sputnik V shows higher Omicron-antibody levels than Pfizer - study
A joint Russian-Italian study compared the blood serum of people who had received the different vaccines.
COVID-19: Pfizer and Moderna prepare vaccine against Omicron
The CEOs of Pfizer and Moderna say they are preparing a booster targeting Omicron. Pfizer CEO Albert Bourla is still unsure if there is a need for the fourth booster.
Pfizer vaccines saved millions of lives, but how good are they really?
The Jerusalem Post Health & Wellness Podcast with Maayan Hoffman and Rossella Tercatin
Merck's COVID-19 pill to arrive in Israel within two weeks
Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus in adults.
